# OptiNose, Inc.

OptiNose, Inc. is a company headquartered in Yardley, PA, United States.

## Company overview

- **Legal name:** OptiNose, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Yardley, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001494650

## About

OptiNose, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001494650, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-26, it reported annual revenue of USD 78,226,000; net income of USD -21,541,000; total assets of USD 128,785,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $78.2M (USD 78,226,000)
- **Net income:** -$21.5M (USD -21,541,000)
- **Total assets:** $128.8M (USD 128,785,000)
- **Cash and equivalents:** $84.5M (USD 84,485,000)
- **Operating cash flow:** -$44.7M (USD -44,680,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $71.0M (USD 70,987,000)
- **Net income:** -$35.5M (USD -35,483,000)
- **Total assets:** $107.7M (USD 107,729,000)
- **Operating cash flow:** -$20.5M (USD -20,532,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $76.3M (USD 76,276,000)
- **Net income:** -$74.8M (USD -74,833,000)
- **Total assets:** $144.2M (USD 144,222,000)
- **Operating cash flow:** -$67.7M (USD -67,651,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $74.7M (USD 74,652,000)
- **Net income:** -$82.3M (USD -82,296,000)
- **Total assets:** $166.1M (USD 166,071,000)
- **Operating cash flow:** -$76.9M (USD -76,935,000)

## Recent SEC filings

- Form 8-K — filed 2025-05-21 — period 2025-05-21 — FORM 8-K
- Form 8-K — filed 2025-05-16 — period 2025-05-16 — FORM 8-K
- Form 10-Q — filed 2025-05-14 — period 2025-03-31 — 10-Q
- Form 10-K/A — filed 2025-04-30 — period 2024-12-31 — FORM-10-K/A
- Form 10-K — filed 2025-03-26 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-26 — period 2025-03-26 — 8-K
- Form 8-K — filed 2025-03-20 — period 2025-03-19 — 8-K
- Form 8-K — filed 2025-03-20 — period 2025-03-19 — 8-K
- Form 8-K — filed 2025-01-15 — period 2025-01-15 — 8-K
- Form 8-K — filed 2024-12-30 — period 2024-12-30 — 8-K
- Form 8-K — filed 2024-12-23 — period 2024-12-23 — 8-K
- Form DEF 14A — filed 2024-12-12 — period 2024-12-12 — DEF 14A

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/optinose-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology